This Article Order Full text via Infotrieve Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Ansari, A. A. Articles by Herskowitz, A. Search for Related Content PubMed PubMed Citation Articles by Ansari, A. A. Articles by Herskowitz, A.

American Journal of Pathology, Vol 139, 337-354, Copyright © 1991 by American Society for Investigative Pathology

REGULAR ARTICLES

Abnormal expression of histocompatibility and mitochondrial antigens by cardiac tissue from patients with myocarditis and dilated cardiomyopathy

AA Ansari, YC Wang, DJ Danner, MB Gravanis, A Mayne, N Neckelmann, KW Sell and A Herskowitz
Department of Pathology, Emory University School of Medicine, Atlanta, Georgia 30322.

Autoantibodies against the adenine nucleotide translocator (ANT), the branched chain alpha-ketoacid dehydrogenase (BCKD) complex proteins, and myosin have been implicated in the pathogenesis of human dilated cardiomyopathy (DCM). Cardiac tissue from patients with DCM and, for control purposes, cardiac tissue from patients with other forms of cardiomyopathy and from patients with no history of cardiac disease were stained with heterologous and ANT-, BCKD-, and myosin-specific affinity-purified sera from DCM patients. Data demonstrate that although anti-myosin stains tissues from both patients and normal controls, the ANT- and BCKD-specific heterologous and affinity-purified sera from DCM patients stain only cardiac tissues from DCM patients. Intense staining in patchy areas of cardiac tissue suggests that abnormal increased expression of these putative autoantigens occurs in discrete areas of cardiac myocytes. The reactivity of the antisera was organ specific and only seen in tissues from DCM patients. The organ and disease specificity of these findings suggests that such expression may play an important role in the pathogenesis of human DCM.

This article has been cited by other articles:

				R. Wojnicz, E. Nowalany-Kozielska, C. Wojciechowska, G. Glanowska, P. Wilczewski, T. Niklewski, M. Zembala, L. Polonski, M. M. Rozek, and J. Wodniecki Randomized, Placebo-Controlled Study for Immunosuppressive Treatment of Inflammatory Dilated Cardiomyopathy : Two-Year Follow-Up Results Circulation, July 3, 2001; 104(1): 39 - 45. [Abstract] [Full Text] [PDF]

				D. T. Kremastinos, P. Flevari, M. Spyropoulou, H. Vrettou, D. Tsiapras, and C. G. Stavropoulos-Giokas Association of Heart Failure in Homozygous {beta}-Thalassemia With the Major Histocompatibility Complex Circulation, November 16, 1999; 100(20): 2074 - 2078. [Abstract] [Full Text] [PDF]

				J. Muller, G. Wallukat, Y.-G. Weng, M. Dandel, S. Spiegelsberger, S. Semrau, K. Brandes, V. Theodoridis, M. Loebe, R. Meyer, et al. Weaning From Mechanical Cardiac Support in Patients With Idiopathic Dilated Cardiomyopathy Circulation, July 15, 1997; 96(2): 542 - 549. [Abstract] [Full Text]

				G. W. Dec and V. Fuster Idiopathic Dilated Cardiomyopathy N. Engl. J. Med., December 8, 1994; 331(23): 1564 - 1575. [Full Text]